Enterotoxemia: Difference between revisions
CSV import |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 47: | Line 47: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
__NOINDEX__ | |||
Latest revision as of 11:01, 17 March 2025
Enterotoxemia, also known as overeating disease or pulpy kidney, is a condition caused by the bacterium Clostridium perfringens type D. This disease primarily affects sheep and goats, but it can also occur in other animals such as cattle and deer. Enterotoxemia is characterized by the sudden death of well-nourished animals, often those that are on a high-nutrient diet.
Pathogenesis[edit]
The disease is caused by the overgrowth of Clostridium perfringens type D in the intestines. This bacterium produces epsilon toxin, which is absorbed into the bloodstream and causes widespread damage to various organs, particularly the kidneys and brain. The overgrowth of the bacteria is often triggered by a sudden change in diet, particularly an increase in carbohydrate-rich feed.
Clinical Signs[edit]
The clinical signs of enterotoxemia can vary, but they often include:
- Sudden death
- Neurological signs such as convulsions, opisthotonos, and ataxia
- Diarrhea, which may be bloody
- Abdominal pain
- Rapid deterioration in condition
Diagnosis[edit]
Diagnosis of enterotoxemia is typically based on clinical signs, history, and post-mortem findings. The presence of Clostridium perfringens type D in the intestines and the detection of epsilon toxin in the intestinal contents or tissues can confirm the diagnosis. Post-mortem findings often include:
- Pulpy kidneys, which are swollen and autolyzed
- Hemorrhages in various organs
- Fluid accumulation in body cavities
Prevention and Control[edit]
Prevention of enterotoxemia involves proper management practices, including:
- Gradual changes in diet to avoid sudden increases in carbohydrate intake
- Vaccination with a multivalent clostridial vaccine, which includes protection against Clostridium perfringens type D
- Ensuring good nutritional management to avoid overfeeding
Treatment[edit]
Treatment of enterotoxemia is often difficult due to the rapid progression of the disease. In early stages, administration of antitoxins and antibiotics may be beneficial. Supportive care, including fluid therapy and anti-inflammatory medications, can also be provided.
Related Pages[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
